The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib in patients (pts) with non-locally pretreated brain metastases (BM) from renal cell carcinoma (RCC): Results of the multicenter CABRAMET phase II trial (NCT03967522).
 
Sylvie Negrier
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; MSD Oncology; Pfizer
Consulting or Advisory Role - Eisai; Ipsen; MSD Oncology
Research Funding - IPSEN (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; IPSEN; MSD; Pfizer
 
Loic Mourey
Honoraria - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; MSD; Pfizer; Sanofi
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; BMS; Eisai; Ipsen; janssen; MSD; Pfizer; Sanofi
 
Ellen Blanc
No Relationships to Disclose
 
Marine Gross-Goupil
Consulting or Advisory Role - Amgen; amgen; Astellas Medivation; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Gilead Sciences; ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Research Funding - Astrazeneca (Inst); Astrazeneca (Inst); BMS (Inst); ipsen (Inst); Janssen-Cilag (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; AstraZeneca; ipsen; ipsen; ipsen; Ipsen; Janssen-Cilag; MSD Oncology; MSD Oncology; pfizer; Pfizer; Roche
 
Aude Flechon
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; NOVARTIS; PFIZER; Roche/Genentech; Sanofi/Aventis
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis
 
Ronan Flippot
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Johnson & Johnson/Janssen; Merck Serono; MSD Oncology; Pfizer
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Pfizer
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; Merck/Pfizer; Merck/Pfizer
 
Philippe Barthelemy
Honoraria - Astellas Pharma; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; SEAGEN
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer
 
Stephane Oudard
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi
Research Funding - AstraZeneca (Inst); Ipsen; Sanofi
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche
 
Emeline Colomba
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Sharp & Dohme
Consulting or Advisory Role - Bayer Health (Inst)
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - Bayer Health; Eisai Europe; Merck Sharp & Dohme
 
Constance Thibault
Honoraria - AAA/Endocyte/Novartis; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer; Sanofi; Seagen
Consulting or Advisory Role - AAA/Endocyte/Novartis; AstraZeneca; Bristol-Meyers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen Oncology; MSD Oncology; Pfizer
 
Alain Ravaud
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai Europe; Ipsen; MSD/Merck; Pfizer
Research Funding - Ipsen (Inst); Merck (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Merck KGaA; Pfizer
 
Christine Chevreau
Consulting or Advisory Role - Bristol-Myers Squibb; ESAÏ; GlaxoSmithKline; Ipsen; Pfizer
Travel, Accommodations, Expenses - IPSEN
 
Mathilde Donnat
No Relationships to Disclose
 
Helen Boyle
Travel, Accommodations, Expenses - IPSEN; Janssen; MSD
 
Cécile Dalban
No Relationships to Disclose
 
David Pérol
Honoraria - Bayer; Daiichi Sankyo Europe GmbH; Gilead Sciences; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Novartis; Roche
 
Bernard Escudier
Honoraria - Ipsen; Oncorena
Consulting or Advisory Role - Ipsen; Oncorena
Travel, Accommodations, Expenses - Ipsen; MSD; Oncrena; Oncrena
 
Laurence Albiges
Consulting or Advisory Role - Astellas Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - BMS; Ipsen; MSD; Pfizer
 
GETUG investigators
No Relationships to Disclose